BIO Welcomes PhRMA’s Revised Code on Interactions with Healthcare Professionals
WASHINGTON, D.C. (July 10, 2008) – BIO President and CEO Jim Greenwood issued the following statement today following the release of the Pharmaceutical Research and Manufacturers of America (PhRMA) revised Code on Interactions with Healthcare Professionals:
“As public dialogue continues over the proper ethical standards guiding interactions between biotechnology innovators and pharmaceutical companies with healthcare professionals, we believe PhRMA’s release of its revised Code is an important contribution to this ongoing dialogue.
“BIO and our member companies remain dedicated to the advancement of medical science and the improvement of patient care. In pursuing this mission, we recognize that adherence to strict ethical standards and compliance with applicable laws is critical to our industry’s ability to continue our collaboration with healthcare professionals and maintain the trust of patients. To that end, we and our member companies continue to encourage the highest standards for ethical business practices and socially responsible industry conduct related to company interactions with healthcare professionals.
“We look forward to continuing to help guide efforts to ensure our member companies adhere to the highest ethical standards.”
Upcoming BIO Events
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Sept. 10-12, 2008
Vancouver, BC
BIO Investor Forum 2008
October 29-31, 2008
San Francisco, CA
BIO-Europe 2008
November 17-19, 2008
Mannheim/Heidelberg, Germany
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###